Don Morris

4.7k citations
93 papers · 3.6k · 1 hit paper · h-index 31

Impact in

  • Virology top 5%
    • HIV Research and Treatment
  • Oncology top 2%
    • CAR-T cell therapy research
    • Cancer Immunotherapy and Biomarkers

Papers in

    • Cancer Immunotherapy and Biomarkers 10
    • CAR-T cell therapy research 10
    • Virus-based gene therapy research 26

Don Morris

91 papers receiving 3.5k citations

Don Morris's Hit Papers

Immune-Related Adverse Events and Survival Among Patients With Metastatic NSCLC Treated With Immune Checkpoint Inhibitors 2024 · 71 citations
710+1Years since publication204060

Peers

Don Morris
Comparison fields: 5 of 123
  • Virology 205
  • Oncology 983
  • Genetics 932
  • Infectious Diseases 559
  • Biotechnology 211
Replace Scott A. Foster with:
Scott A. Foster United States
G W Demers United States
Joëlle Wiels France
Craig P. Webb United States
Robson Q. Monteiro Brazil
Hans de Haard Belgium
Tsuneya Ohno Japan
Marie‐Annick Buendia France
Neil Steven United Kingdom
James L. Murray United States
Don Morris relative to Scott A. Foster United States Scott A. Foster's profile →
Citations per field
00.5×1.5×
Scott A. Foster · 1×
Citations per year

Countries citing papers authored by Don Morris

Since Specialization
Citations

This map shows the geographic impact of Don Morris's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Don Morris with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Don Morris more than expected).

Fields of papers citing papers by Don Morris

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Don Morris. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Don Morris. The network helps show where Don Morris may publish in the future.

Co-authors

The 25 scholars most cited alongside Don Morris, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Don Morris Line = papers co-authored together Don Morris links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 93 papers — load more, or switch the sort, to bring in the rest.

#Work
1 1996453
2 1996440
3 2008237
4 1999216
5 2001193
6 2015126
7 2003107
8 199496
9 201292
10 201080
11
Immune-Related Adverse Events and Survival Among Patients With Metastatic NSCLC Treated With Immune Checkpoint Inhibitors
Hit paper breakdown →
202471
12 202065
13 201162
14 201260
15 201859
16 201757
17 201957
18 200552
19 201848
20 201546

About Don Morris

Don Morris is a scholar working on Oncology, Genetics, Pulmonary and Respiratory Medicine, Molecular Biology and Biotechnology, having authored 93 papers that have together received 3.6k indexed citations. Recurring topics across this work include Virus-based gene therapy research (26 papers), Lung Cancer Treatments and Mutations (12 papers), Cancer Research and Treatments (11 papers), Cancer Immunotherapy and Biomarkers (10 papers), CAR-T cell therapy research (10 papers), Viral gastroenteritis research and epidemiology (9 papers), Hematopoietic Stem Cell Transplantation (7 papers) and Sarcoma Diagnosis and Treatment (6 papers). The work is most often cited by research in Virology (205 citations), Oncology (983 citations), Genetics (932 citations), Infectious Diseases (559 citations) and Biotechnology (211 citations). Don Morris has collaborated with scholars based in Canada, United States and Japan. Frequent co-authors include Ronald W. Davis, Daniel Shoemaker, Deval Lashkari, Chandini M. Thirukkumaran, Peter Forsyth, Naiping Shen, Michael J. Kozal, Nila Shah, Earl Hubbell and Daniel E. Meyers. Their work appears in journals such as Bone Marrow Transplantation, Cancer Research, PLoS ONE, JNCI Journal of the National Cancer Institute and Cancers.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact